Glimtin M 0.5mg/500mg Tablet
By Glimtin M
Rx
15 Tablet in a Strip

Composition
Glimepiride(0.5mg) + Metformin(500mg)

Manufacturer - Shinto Organics (P) Limited
110, Industrial Area, Phase-II, Panchkula (Haryana) - 134113

Expires on or after
September, 2025
About Glimtin M 0.5mg/500mg Tablet
Glimtin M 0.5mg/500mg Tablet is classified as an anti-diabetic medication that combines two drugs to manage type 2 diabetes mellitus in adults. It is designed to help regulate blood sugar levels in individuals with diabetes. Remember to consume Glimtin M 0.5mg/500mg Tablet alongside meals, at consistent intervals each day, to maximize its effectiveness. The dosage prescribed will be determined by your doctor and may be adjusted based on your blood sugar readings over time.
Consistent usage of Glimtin M 0.5mg/500mg Tablet is crucial, even if you feel well or have your blood sugar under control. Discontinuing the medication without medical consultation could result in an escalation of blood sugar levels, heightening the risk of kidney complications, vision impairment, nerve issues, and limb loss. It's essential to comprehend that this medication is only one component of an overall treatment strategy, which should also encompass a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle adjustments are instrumental in managing diabetes effectively.
The primary adverse effect associated with Glimtin M 0.5mg/500mg Tablet is hypoglycemia (low blood glucose levels). Recognizing the indicators of hypoglycemia such as perspiration, lightheadedness, headaches, and tremors is imperative, alongside understanding the appropriate responses. To prevent hypoglycemia, maintaining regular mealtimes and carrying a rapid-acting glucose source like sugary snacks or fruit juice is crucial. Consumption of alcohol can escalate the risk of hypoglycemia and is best avoided. Other potential side effects may include alterations in taste perception, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory tract infections. Weight gain may also be observed in some individuals using this medication.
Individuals with type 1 diabetes mellitus, diabetic ketoacidosis, severe kidney or liver issues, or a history of heart disease are not recommended to take Glimtin M 0.5mg/500mg Tablet. It is imperative to inform your doctor if you are pregnant, breastfeeding, or have experienced heart problems before commencing this medication. Regular monitoring of blood sugar levels is essential, and periodic blood tests may be advised to evaluate blood cell counts and liver function.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹54
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024